Original research| Volume 11, ISSUE 1, P52-56, February 2017

Download started.


Psoriasis risk in patients with type 2 diabetes in German primary care practices


      • The study included 72,148 type 2 diabetes patients and 72,148 non-diabetic controls.
      • 3.4% of diabetes patients and 2.8% of controls developed psoriasis within ten years of follow-up.
      • Diabetes was positively associated with psoriasis in German primary care practices.



      To analyze psoriasis risk in type 2 diabetes mellitus (T2DM) patients treated in German primary care practices.


      The study included 87,964 T2DM patients aged 40 years or over who received their initial diabetes diagnosis between 2004 and 2013. Patients were excluded if they had been diagnosed with psoriasis prior to diabetes diagnosis or if the observation period prior to the index date was less than 365 days. After applying these exclusion criteria, 72,148 T2DM patients were included. A total of 72,148 non-diabetic controls were matched (1:1) to T2DM cases based on age, gender, type of health insurance (private or statutory), number of medical visits, and index date. The primary outcome was the diagnosis of psoriasis. Skin infections, dermatitis/eczema, hyperlipidemia, and medications associated with psoriasis (beta blockers, angiotensin-converting enzyme (ACE) inhibitors, lithium, antimalarials, nonsteroidal anti-inflammatory drugs, and benzodiazepines) were included as potential confounders.


      The mean age was 68.7 years (SD = 12.7 years) and 48.6% of subjects were men. Hyperlipidemia, dermatitis/eczema, and skin infections were more frequent in T2DM patients than in controls. Beta blockers, ACE inhibitors, and nonsteroidal anti-inflammatory drugs were also more commonly used in people with T2DM than in controls. A total of 3.4% of T2DM patients and 2.8% of matched controls developed psoriasis within ten years of follow-up (p-value <0.001). T2DM patients were at a higher risk of developing psoriasis than controls (HR = 1.18, 95% CI: 1.08–1.29).


      T2DM was positively associated with psoriasis in patients treated in German primary care practices.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • WHO
        10 Facts about Diabetes.
        WHO, 2016 (accessed 23.02.16)
      1. Statistics.
        Deutsches Zentrum für Diabetesforschung (DZD), 2016 (accessed (23.02.16))
        • Huxley R.
        • Barzi F.
        • Woodward M.
        Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.
        BMJ. 2006; 332 (PMID: 16371403): 73-78
      2. The Emerging Risk Factors Collaboration: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
        Lancet. 2010; 375: 2215-2222
        • Nouwen A.
        • Winkley K.
        • Twisk J.
        • Lloyd C.E.
        • Peyrot M.
        • Ismail K.
        • Pouwer F.
        • Consortium for the ED in D (EDID) R
        Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis.
        Diabetologia. 2010; 53: 2480-2486
        • Shapiro J.
        • Cohen A.D.
        • David M.
        • Hodak E.
        • Chodik G.
        • Viner A.
        • Kremer E.
        • Heymann A.
        The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case–control study.
        J. Am. Acad. Dermatol. 2007; 56: 629-634
        • Cohen A.
        • Dreiher J.
        • Shapiro Y.
        • Vidavsky L.
        • Vardy D.
        • Davidovici B.
        • Meyerovitch J.
        Psoriasis and diabetes: a population-based cross-sectional study.
        J. Eur. Acad. Dermatol. Venereol. 2008; 22: 585-589
        • Qureshi A.A.
        • Choi H.K.
        • Setty A.R.
        • Curhan G.C.
        Psoriasis and the risk of diabetes and hypertension: a prospective study of us female nurses.
        Arch. Dermatol. 2009; 145: 379-382
        • Armstrong A.W.
        • Harskamp C.T.
        • Armstrong E.J.
        Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis.
        JAMA Dermatol. 2013; 149: 84-91
        • Becher H.
        • Kostev K.
        • Schröder-Bernhardi D.
        Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
        Int. J. Clin. Pharmacol. Ther. 2009; 47 (PMID: 19825325): 617-626
        • Kostev K.
        • Dippel F.W.
        • Rathmann W.
        Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care.
        Prim. Care Diabetes. 2015; (PMID: 26324105)
        • Jacob L.
        • Kostev K.
        Prevalence of depression in type 2 diabetes patients in German primary care practices.
        J. Diabetes Complicat. 2015; ([doi: 10.1016/j.jdiacomp.2015.12.013] [PMID: 26790576])
        • Jacob L.
        • Waehlert L.
        • Kostev K.
        Changes in Type 2 diabetes mellitus patients in German primary care prior to (2006) and after (2010, 2014) launch of new drugs.
        J. Diabetes Sci. Technol. 2016; (PMID: 26864513)
        • Kim G.K.
        • Del Rosso J.Q.
        Drug-provoked psoriasis: is it drug induced or drug aggravated? Understanding pathophysiology and clinical relevance.
        J. Clin. Aesthet. Dermatol. 2010; 3 (PMID: 20725536): 32-38
        • Setty A.R.
        • Curhan G.
        • Choi H.K.
        Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ health study II.
        Arch. Intern. Med. 2007; 167: 1670-1675
        • Hu F.B.
        • Manson J.E.
        • Stampfer M.J.
        • Colditz G.
        • Liu S.
        • Solomon C.G.
        • Willett W.C.
        Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
        N. Engl. J. Med. 2001; 345 (PMID. 11556298): 790-797
        • Peyrot M.
        • Rubin R.R.
        Levels and risks of depression and anxiety symptomatology among diabetic adults.
        Diabetes Care. 1997; 20 (PMID: 9096984): 585-590
        • Esposito M.
        • Saraceno R.
        • Giunta A.
        • Maccarone M.
        • Chimenti S.
        An Italian study on psoriasis and depression.
        Dermatol. Basel Switz. 2006; 212 (PMID: 16484818): 123-127
        • Hayes J.
        • Koo J.
        Psoriasis: depression, anxiety, smoking, and drinking habits.
        Dermatol. Ther. 2010; 23: 174-180
        • Muller L.M.A.J.
        • Gorter K.J.
        • Hak E.
        • Goudzwaard W.L.
        • Schellevis F.G.
        • Hoepelman A.I.M.
        • Rutten G.E.H.M.
        Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.
        Clin. Infect. Dis. 2005; 41 (PMID: 16007521): 281-288
        • Huerta C.
        • Rivero E.
        • Rodríguez L.A.G.
        Incidence and risk factors for psoriasis in the general population.
        Arch. Dermatol. 2007; 143 (PMID: 18087008): 1559-1565